Cây Cối có Công Dụng Truyền Thống và Hoạt Động Liên Quan đến Việc Quản Lý Bệnh Alzheimer và Các Rối Loạn Nhận Thức Khác
Tóm tắt
Trong thực hành y học truyền thống, nhiều loại cây đã được sử dụng để điều trị các rối loạn nhận thức, bao gồm các bệnh thoái hóa thần kinh như bệnh Alzheimer (AD) và các rối loạn liên quan đến trí nhớ khác. Một cách tiếp cận dược lý dân tộc đã cung cấp những hướng đi trong việc xác định các loại thuốc mới tiềm năng từ nguồn gốc thực vật, bao gồm cả thuốc điều trị các rối loạn trí nhớ. Có nhiều loại thuốc trong y học Tây phương đã được chiết xuất trực tiếp từ thực vật, hoặc có nguồn gốc từ các mẫu hợp chất từ cây cối. Ví dụ, một số alcaloid từ nguồn thực vật đã được nghiên cứu về tiềm năng của nó trong liệu pháp điều trị AD, và hiện đang được sử dụng trong lâm sàng (ví dụ: galantamine từ
Từ khóa
Tài liệu tham khảo
Aesbach R, 1994, Antioxidant actions of thymol, carvacrol, 6‐gingerol, zingerone and hydroxytyrosol, Food Chem Toxic, 46, 1739
Anbalagan K, 1981, Response of α‐1 globulins of serum during inflammation, Curr Sci, 50, 88
Anbalagan K, 1981, Influence of Indian medicine (ashwagandha) on acute‐phase reactants in inflammation, Indian J Exp Biol, 19, 245
Anbalagan K, 1985, Withania somnifera (ashwagandha), a rejuvenating herbal drug which controls α‐2 macroglobulin synthesis during inflammation, Int J Crude Drug Res, 23, 177, 10.3109/13880208509069028
Begum V, 1988, Long term effect of herbal drug Withania somnifera on adjuvant induced arthritis in rats, Indian J Exp Biol, 26, 887
Bhattacharya SK, 1997, Anti‐oxidant activity of glycowithanolides from Withania somnifera, Indian J Exp Biol, 35, 236
Bickel U, Pharmacokinetics of galanthamine in humans and corresponding cholinesterase inhibition, Clin Pharmacol, 50, 420
Bisset NG, 1994, Herbal Drugs and Phytopharmaceuticals
Bores GM, 1996, Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine, Am Soc Pharmacol Exp Ther, 277, 728
Braquet PG, 1994, Ginkgolide B (BN 52021): a natural PAF receptor antagonist, Neuropsychopharmacology., 10, 693S
Chang H, 1987
Craig WJ, 1999, Health‐promoting properties of common herbs, Am J Clin Nutr, 70, 491S, 10.1093/ajcn/70.3.491s
Cutler NR, 1999, Correlation between cognitive effects and level of acetylcholinesterase inhibition in a trial of rivastigmine in Alzheimer patients, Neurology, 52, A173
Das PK, 1964, Cardiotonic activity of ashwagandhine, two alkaloids from Withania ashwagandha, Kaul, Arch Int Pharmacodyn, 150, 356
Deans SG, 1993, Role of Free Radicals in Biological Systems, 159
Duke JA, 1985
Evans DA, 1989, Prevalence of Alzheimer's disease in a community population of older persons, JAMA, 262, 2551, 10.1001/jama.1989.03430180093036
Evans J, 2001, New paths to Alzheimer's drugs, Chem Britain, 37, 47
Fan S, 1979, Experimental analysis of the prompt curative effect of Salvia compositus, Acta Pharm Sinica, 14, 199
Flores CM, 1992, A subtype of nicotinic cholinergic receptor is composed of Á4 and ß2 subunits and is upregulated by chronic nicotine treatment, Mol Pharmacol, 41, 31
Förstl H, 1995, Age‐associated memory impairment and early Alzheimer's disease, Drug Res, 45, 394
Foster S, 1989, Huperzia: hype or hope?, HerbalGram, 18, 21
Graves AB, 1994, Does smoking reduce the risks of Parkinson's and Alzheimer's diseases?, J Smoking‐Related Disord, 5, 79
GrossbergGet al. DesaiA.2001.Review of rivastigmine and its clinical applications in Alzheimer's disease and related disorders.2:653–666.
Guanhua D, 1997, Protective effects of salvianolic acid A against impairment of memory induced by cerebral ischemia‐reperfusion in mice, Chin Med J (Engl), 110, 65
Guenther E, 1949, Individual Essential Oils of the Plant Families Rutaceae and Labiatae
Handa SS, 1992, Plants with anti‐inflammatory activity, Fitoterapia, 63, 3
Harborne JB, 1993, Phytochemical Dictionary
Heiss WD, 1978, Drug influence on cerebral circulation, Pharmakotherapie, 1, 137
Huang KC, 1993, The Pharmacology of Chinese Herbs
Huang YS, 1992, Antioxidative effect of three water‐soluble components isolated from Salvia miltiorrhiza in vitro, Acta Pharm Sinica, 27, 96
Kapoor LD, 1990, Handbook of Ayurvedic Medicinal Plants
Kennedy DO, 2002, Acute mood and cognitive effects of oil of Salvia lavandulaefolia (Spanish sage) in healthy young volunteers, Pharmacology, Biochemistry and Behaviour
Kenner D, 1996, Botanical Medicine: A European Professional Perspective
Kristofiková Z, 1992, Changes of high‐affinity choline uptake in the hippocampus of old rats after long‐term administration of two nootropic drugs (tacrine and Ginkgo biloba extract), Dementia, 3, 304
Kuang P, 1995, Protective effect of Radix Salviae miltiorrhizae composita on cerebral ischemia, J Tradit Chin Med, 15, 135
Kuang P, 1996, Effect of Radix Salviae miltiorrhizae on nitric oxide in cerebral ischemic‐reperfusion injury, J Tradit Chin Med, 16, 224
Kuang P, 1996, Radix Salviae miltiorrhizae treatment results in decreased lipid peroxidation in reperfusion injury, J Tradit Chin Med, 16, 138
Kuang P, 1991, The effect of Radix Salviae miltiorrhizae (RSM) on substance P in cerebral ischemia—animal experiment, J Tradit Chin Med, 11, 123
Kuang P, 1989, The effect of Radix Salviae miltiorrhizae on vasoactive intestinal peptide in cerebral ischaemia: an animal experiment, J Tradit Chin Med, 9, 203
Kuang P, 1993, Evidence for amelioration of cellular damage in ischemic rat brain by Radix Salviae miltiorrhizae treatment—immunochemistry and histopathology studies, J Tradit Chin Med, 13, 38
Kuang P, 1994, Effect of Radix Salviae miltiorrhizae on EAA and IAA during cerebral ischemia in gerbils: a microdialysis study, J Tradit Chin Med, 14, 45
Kumar V, 2001, Anti‐inflammatory and analgesic activity of Indian Hypericum perforatum L, Indian J Exp Biol, 39, 339
Kumar V, 1999, Efficacy and safety of rivastigmine (Exelon) in Alzheimer's disease patients with vascular risk factors, Neurology, 52, A395
Lamaison JL, 1991, Medicinal Lamiaceae with antioxidative activity, potential sources of rosmarinic acid, Pharm Acta Helv, 66, 185
Le Bars PL, 1997, A placebo‐controlled, double‐blind, randomised trial of an extract of Ginkgo biloba for dementia, JAMA, 278, 1327, 10.1001/jama.1997.03550160047037
Lee MK, 2000, Asiatic acid derivatives protect cultured neurons from glutamate‐induced excitotoxicity, Res Commun Mol Pathol Pharmacol, 108, 75
Lu W‐H, 1988, Improving effect of huperzine A in aged rats and adult rats with experimental cognitive impairment, Acta Pharm Sinica, 9, 11
Malhotra CL, 1965, Studies on Withania Aswagandha, Kaul. V. The effects of total alkaloids (ashwagandholine) on the central nervous system, Indian J Physiol Pharmacol, 9, 127
McCaleb R, 1990, Nature's medicine for memory loss, HerbalGram, 23, 15
McGuffey EC, 1997, Alzheimer's disease: an overview for the pharmacist, JAMA, 37, 347
McVicar J, 1994, Jekka's Complete Herb Book
Mehta AK, 1991, Pharmacological effects of Withania somnifera root extract on GABAA receptor complex, Indian J Med Res Section B. Biomed Res Other Than Infect Diss., 94, 312
Mills S, 2000, Principles and Practice of Phytotherapy
Mishra L, 2000, Scientific basis for the therapeutic use of Withania somnifera. (ashwagandha): a review, Alter Med Rev, 5, 334
Moncada S, 1991, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol Rev, 43, 109
Nalini K, 1992, Effect of Centella asiatica fresh leaf aqueous extract on learning and memory and biogenic amine turnover in albino rats, Fitoterapia, 63, 232
Newall CA, 1996, Herbal Medicines—A Guide for Health Professionals
Ohkura T, 1994, Low‐dose estrogen replacement therapy for Alzheimer disease in women, Menopause: The J N Am Menopause Soc, 1, 125
Panda S, 1997, Protective role of ashwagandha in cadmium‐induced hepatotoxicity and nephrotoxicity in male mouse, Curr Sci, 72, 546
Paulus K, 2000, Natural Products Research in the New Millenium Abstract Book
Peigen K, 1996, Radix Salviae miltiorrhizae treatment results in decreased lipid peroxidation in reperfusion injury, J Tradit Chin Med, 16, 138
Perry NSL, 2000, Sage: The Genus Salvia, 207
Read SL, 1987, Update on cholinergic enhancement therapy for Alzheimer disease, Bull Clin Neurosci, 52, 34
Ross IA, 2001, Chemical Constituents, Traditional and Modern Medicinal Uses
Sakina MR, 1990, A psycho‐neuropharmacological profile of Centella asiatica extract, Fitoterapia, 61, 291
Schwarting AE, 1963, The alkaloids of Withania somnifera, Lloydia, 26, 258
Small GW, 1997, Diagnosis and treatment of Alzheimer's disease and related disorders, JAMA, 278, 1363
Song LC, 1992, The effect of Coptis chinensis on lipid peroxidation and antioxidases activity in rats, Zhongguo Zhong Xi Yi Jie He Za Zhi, 12, 421
Spiteller G, 1993, Review: on the chemistry of oxidative stress, J Lipid Mediators, 7, 199
Tea S, 1987, Quantified parameters for the proof of the enhancement of cerebral circulation and metabolism, Therapiewoche, 37, 2655
Upton R, 2000, Ashwagandha root. Withania somnifera. Analytical, quality control and therapeutic monograph, Am Herbal Pharm Ther Compendium, 1
Wang LJ, 1998, Extract of dangshen (Codonopsis pilulosa) can reduce the impairment of memory acquisition in mice, Naunyn Schmiedebergs Arch Pharmacol, 358, P5174
Wang Y‐E, 1986, Anti‐cholinesterase activity of huperzine A, Acta Pharm Sinica, 7, 110
Welton AF, 1986, Effect of flavonoids on arachidonic acid metabolism, Prog Clin Biol Res, 213, 231
Yamada H, 1997, Anti‐dementia actions of Kampo (Japanese‐herbal) medicines effects of Kampo medicines on central nervous system, Curr Top Phytochem, 1, 157
Younkin SG, 1986, Molecular forms of acetylcholinesterase in Alzheimer's disease, Fed Proc, 45, 2982
Zhang X, 1994, The effect of Radix Salviae miltiorrhizae composita on peroxidation of low density lipoprotein due to copper dichloride, J Tradit Chin Med, 14, 195
Zhao B, 1996, Scavenging effects of Salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia‐reperfusion injury, Biochem Mol Biol Int, 38, 1171
Zhou Y, 1992, Antioxidative effect of Chinese drugs, Zhongguo Zhong Yao Za Zhi, 17, 368